This isn’t XEME Biopharma Holdings Inc.’s most recent raise. Reg A+ · Equity · Nov 2019 (Closed) is more current.View latest round
via the platform · last checked Sep 24, 2026
Raised
$0 / $20M max
0% of ceiling
Investors
—
—
Valuation
—
—
Financials disclosed in this offering
No financial statements linked to this round
The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.
Deal terms
Price / share$0.20
Shares offered100,000,000
Offering details
Target—
Max$20,000,000
Min investment—
OpenedSep 25, 2019
Deadline—
Days active2,557
Links & provenance
Source: SEC EDGAR
0001775196-19-000006
Last synced Sep 24, 2026
0001775196-19-000006
Last synced Sep 24, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.